Clinical trial
A Phase II Single-arm Trial of BIBW 2992 in Demographically and Genotypically Selected NSCLC
NCT00730925 is registered in ClinicalTrials.gov with Boehringer Ingelheim as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase II Single-arm Trial of BIBW 2992 in Demographically and Genotypically Selected NSCLC
- Lead sponsor
- Boehringer Ingelheim
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- June 30, 2008
- Completion date
- Not reported
- Enrollment
- 41 (actual)
- Sites
- 7
Conditions
As the registry lists them; a condition with its own page is linked.